"Gazeta Giełdy Parkiet" in the publication from 3rd July presents the opinion of the brokerage homes analysts regarding the perspective on the pharmaceuticals' distribution. The analysts cited by the Daily admit NEUCA shows the biggest chances for growths among the stock listed competitors.

The company has been positively evaluated by the analysts mainly due to the good management by the Board, potential benefits coming from the synergy after the ACP Pharma takeover and the development of the private brand pharmaceuticals. The representatives of the brokerage homes also stress NEUCA searches for new sources of profits.

In the BZ WBK Brokerage Home, Tomasz Sokołowski, analyst NEUCA is the market favourite and shows a long-term growth strategy. The expert focuses on the organised structure of the Group and competitive advantage that is the biggest market share. Sylwia Jaśkiewicz, BOŚ Brokerage Home analyst, spoke similarly stating she expects equally good results for the 2nd quarter of 2015.

distributed by